How many patents does
Abbott have?
patents
16,892
families
1,942
granted
3,684
applications
13,208
US
3,646
EP
2,135
WO
1,193
CN
1,060
JP
709
KR
372
GB
7
RoW
7,770
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Abbott
Top ten assignees appearing on patents
2009 - 2018
| abbott | 11424 |
| abbvie | 2582 |
| abbvie deutschland & company | 534 |
| abbvie bahamas | 455 |
| abbvie biotechnology | 223 |
| enanta pharmaceuticals | 138 |
| abbott biotechnology | 129 |
| abbott molecular | 108 |
| abbvie ireland unlimited company | 97 |
| ericsson, anna m. | 76 |
2018
Abbott
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| anti-viral compounds | 132 | 2009 |
| anti-viral compounds | 127 | 2009 |
| macrocyclic hepatitis c serine protease inhibitors | 115 | 2008 |
| apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | 105 | 2009 |
| methods of administering anti-tnf alpha antibodies | 98 | 2001 |
| solid pharmaceutical dosage form | 98 | 2003 |
| phosphine ligands for catalytic reactions | 95 | 2010 |
| formulation of human antibodies for treating tnf-alpha associated disorders | 93 | 2002 |
| monoclonal antibodies against amyloid beta protein and uses thereof | 89 | 2005 |
| human antibodies that bind human tnfalpha | 84 | 1996 |